Aptilon Corp – Filings and Transcripts

OTC: APTOF
Share price (7/2/26): $1.69
Market cap (7/2/26): $337 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Securities registration termination

Going private transaction – amended

Going private transaction – amended

Registration withdrawal request

Going private transaction – amended

Ownership Filter

Seizinger Bernd R.

Whitehead Warren

Vincent Mark D.

Rice William G.

News Filter

Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical

Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical

Aptose Presents Safety, Response, and MRD Clinical Data From TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement With Hanmi Pharmaceutical

Aptose Reports First Quarter 2026 Results

Proxies Filter

Proxy related to merger

Preliminary revised proxy

Preliminary revised proxy

Preliminary revised proxy

Preliminary proxy related to merger

Other Filter

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC